We are live on
!
Find out more
GA
GuoLine Advisory Portfolio holdings
AUM
$1.07B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
-4.51%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$945M
AUM Growth
-$24.6M
(-2.5%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
3.8%
Top 10 Holdings %
Top 10 Hldgs %
61.48%
Holding
23
New
2
Increased
3
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$32.9M |
| 2 |
TSMC
TSM
|
+$14.2M |
| 3 |
ServiceNow
NOW
|
+$7.55M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$6.84M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$6.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$6.73M |
| 2 |
Mastercard
MA
|
+$6.59M |
| 3 |
GE HealthCare
GEHC
|
+$6.57M |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$6.29M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$6.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.96% |
| 2 | Healthcare | 20.85% |
| 3 | Financials | 20.2% |
| 4 | Communication Services | 11.23% |
| 5 | Consumer Discretionary | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.45T
| $90.4M | 9.57% |
240,900
| – | – |
|
2
Apple
AAPL
$4.54T
| $82.6M | 8.74% |
371,700
| – | – |
|
3
Alphabet (Google) Class A
GOOGL
$4.36T
| $76.7M | 8.12% |
496,000
| – | – |
|
|
4
Visa
V
$684B
| $56.1M | 5.94% |
160,100
-19,900
| -11% | -$6.73M |
|
|
5
Mastercard
MA
$502B
| $55.3M | 5.86% |
100,900
-12,100
| -11% | -$6.59M |
|
6
Amazon
AMZN
$2.92T
| $54.4M | 5.75% |
285,680
| – | – |
|
7
S&P Global
SPGI
$121B
| $46.4M | 4.92% |
91,400
| – | – |
|
|
8
ServiceNow
NOW
$115B
| $41M | 4.34% |
257,400
+39,150
| +18% | +$7.55M |
|
|
9
Thermo Fisher Scientific
TMO
$213B
| $39.2M | 4.15% |
78,800
-11,200
| -12% | -$6.07M |
|
10
Vertex Pharmaceuticals
VRTX
$121B
| $38.6M | 4.09% |
79,700
| – | – |
|
11
Zscaler
ZS
$24.5B
| $37.9M | 4.01% |
191,060
| – | – |
|
|
12
Regeneron Pharmaceuticals
REGN
$78.5B
| $35.7M | 3.78% |
56,300
+9,940
| +21% | +$6.84M |
|
13
KLA
KLAC
$239B
| $35.7M | 3.78% |
525,000
| – | – |
|
|
14
Arthur J. Gallagher & Co
AJG
$64.1B
| $33M | 3.49% |
95,500
-19,900
| -17% | -$6.29M |
|
15
Salesforce
CRM
$151B
| $31.6M | 3.35% |
117,890
| – | – |
|
|
NVO
16
Novo Nordisk
NVO
$208B
| $29.6M | 3.14% |
426,700
+80,200
| +23% | +$6.62M |
|
|
17
Meta Platforms (Facebook)
META
$1.42T
| $29.4M | 3.11% |
+51,000
| New | +$32.9M |
|
18
Zoetis
ZTS
$32.4B
| $28.7M | 3.04% |
174,400
| – | – |
|
|
19
GE HealthCare
GEHC
$30.7B
| $25.1M | 2.65% |
310,700
-76,400
| -20% | -$6.57M |
|
20
Palo Alto Networks
PANW
$270B
| $23.1M | 2.44% |
135,200
| – | – |
|
21
Adobe
ADBE
$99.5B
| $23M | 2.44% |
60,020
| – | – |
|
22
CrowdStrike
CRWD
$194B
| $18.9M | 2% |
214,400
| – | – |
|
|
23
TSMC
TSM
$2.1T
| $12.1M | 1.28% |
+73,000
| New | +$14.2M |
|
Similar funds
SCM
PP
DCP
ZIG
EC
FNT
TAM
EG
GuoLine Advisory's Q1 2025 Portfolio in Review
As of Q1 2025, GuoLine Advisory held 23 positions worth $945M, down 2.5% from $969M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
GuoLine Advisory deployed $35.9M of net new capital in Q1 2025, opening 2 new positions and adding to 3 existing holdings. Its largest new stake was Meta Platforms (Facebook): 51,000 shares worth $29.4M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 43% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Visa, an estimated $6.73M trimmed.
- GuoLine Advisory's largest Q1 2025 buy was Meta Platforms (Facebook): 51,000 shares worth $29.4M.
- GuoLine Advisory added most to ServiceNow in Q1 2025, an estimated $7.55M increase.
- GuoLine Advisory's biggest Q1 2025 reduction was Visa, cutting an estimated $6.73M.
- GuoLine Advisory's ten largest holdings make up 61% of its $945M portfolio in Q1 2025.
- GuoLine Advisory opened 2 new positions and closed 0 in Q1 2025.
- GuoLine Advisory's portfolio value fell 2.5% quarter-over-quarter to $945M.
Based on GuoLine Advisory's 13F filing for Q1 2025, filed 8 Apr 2025.